Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists

  • Awadhesh Kumar Singh, Ritu Singh
  • Expert Review of Clinical Pharmacology, April 2017, Taylor & Francis
  • DOI: 10.1080/17512433.2017.1318061

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/17512433.2017.1318061

The following have contributed to this page: Dr Awadhesh Kumar Singh